173 related articles for article (PubMed ID: 4036385)
1. [Possibilities for the use of exfoliative urine cytology in invasive and noninvasive bladder cancer].
Stadie G; Ebert W; Müller H
Z Urol Nephrol; 1985 Jun; 78(6):331-7. PubMed ID: 4036385
[TBL] [Abstract][Full Text] [Related]
2. Urinary cytology in the detection of bladder tumours. Influence of concomitant urothelial atypia.
Harving N; Petersen SE; Melsen F; Wolf H
Scand J Urol Nephrol Suppl; 1989; 125():127-31. PubMed ID: 2633311
[TBL] [Abstract][Full Text] [Related]
3. Urine cytology in bladder tumors.
Zein TA; Milad MF
Int Surg; 1991; 76(1):52-4. PubMed ID: 2045253
[TBL] [Abstract][Full Text] [Related]
4. [What is the value of urine cytology in after-care of patients with urothelial cancers?].
Möllhoff S; Rathert P
Urologe A; 1992 Jul; 31(4):203-5. PubMed ID: 1514198
[No Abstract] [Full Text] [Related]
5. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
6. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
[TBL] [Abstract][Full Text] [Related]
7. [Dysplastic urothelial changes in patients with bladder cancer].
Csapó Z; Kolozsy Z; Dauda G; Mohácsi L
Urologe A; 1984 Sep; 23(5):281-4. PubMed ID: 6542270
[TBL] [Abstract][Full Text] [Related]
8. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
Kumar A; Kumar R; Gupta NP
Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358
[TBL] [Abstract][Full Text] [Related]
9. Is urinary tract cytology still useful for diagnosis of bladder carcinomas? A large series of 592 bladder washings using a five-category classification of different cytological diagnoses.
Garbar C; Mascaux C; Wespes E
Cytopathology; 2007 Apr; 18(2):79-83. PubMed ID: 17397491
[TBL] [Abstract][Full Text] [Related]
10. [Value of exfoliative cytology of the urinary bladder in occult bladder cancer and in the control of treated cancers].
Schmitz A; Meyer U; Kierfeld G; Küchemann K
Urologe A; 1984 Sep; 23(5):278-80. PubMed ID: 6542269
[TBL] [Abstract][Full Text] [Related]
11. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
12. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.
Skacel M; Fahmy M; Brainard JA; Pettay JD; Biscotti CV; Liou LS; Procop GW; Jones JS; Ulchaker J; Zippe CD; Tubbs RR
J Urol; 2003 Jun; 169(6):2101-5. PubMed ID: 12771727
[TBL] [Abstract][Full Text] [Related]
13. [The significance of urine cytology three consecutive days after transurethral resection as a predictor of superficial bladder cancer recurrence].
Yumura Y; Takase K; Kato Y; Hamano A; Mikata K; Ogo Y; Noguchi S; Satomi Y
Hinyokika Kiyo; 2004 Mar; 50(3):171-6. PubMed ID: 15148768
[TBL] [Abstract][Full Text] [Related]
14. Surveillance of patients with bladder carcinoma using fluorescent in-situ hybridization on bladder washings.
Bergman J; Reznichek RC; Rajfer J
BJU Int; 2008 Jan; 101(1):26-9. PubMed ID: 17850364
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of the ImmunoCyt assay in the diagnosis of transitional cell carcinoma of the urinary bladder.
Feil G; Zumbrägel A; Päulgen-Nelde HJ; Hennenlotter J; Maurer S; Krause S; Bichler KH; Stenzl A
Anticancer Res; 2003; 23(2A):963-7. PubMed ID: 12820331
[TBL] [Abstract][Full Text] [Related]
16. The value of upper tract cytology after transurethral resection of bladder tumor in patients with bladder transitional cell cancer.
Sadek S; Soloway MS; Hook S; Civantos F
J Urol; 1999 Jan; 161(1):77-9; discussion 79-80. PubMed ID: 10037373
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
[TBL] [Abstract][Full Text] [Related]
19. [Dedifferentiated superficial bladder cancer with invasion of the lamina propria (pT1 GIII)].
Flamm J
Z Urol Nephrol; 1986 Sep; 79(9):511-6. PubMed ID: 3788301
[TBL] [Abstract][Full Text] [Related]
20. Cytohistological study of urinary bladder neoplasms.
Misra V; Gupta SC; Tandon SP; Gupta AK; Sircar S
Indian J Pathol Microbiol; 2000 Jul; 43(3):303-9. PubMed ID: 11218677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
